ArticleNeurobiology of disease2016

A CaV2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant.

Shehrazade Dahimene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.